Immunomodulation‐Enhanced Nanozyme‐Based Tumor Catalytic Therapy
2020 · Advanced Materials · 366 citations
https://doi.org/10.1002/adma.202003563
S
Shuang Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
139
Papers
5.4K
Citations
40
h-index
83
i10-index
Shuang Wang is an academic researcher from Jiangsu University. The author has contributed to research in topics: Nanoplatforms for cancer theranostics & Cancer-related gene regulation & RNA Interference and Gene Delivery. The author has an h-index of 40, co-authored 119 publications.
ORCID: 0000-0002-9189-602XPapers by this author
worksRETRACTED ARTICLE: Epstein–Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma
2015 · Nature Communications · 212 citations
https://doi.org/10.1038/ncomms8353
Engineered biomimetic nanoparticles achieve targeted delivery and efficient metabolism-based synergistic therapy against glioblastoma
2022 · Nature Communications · 179 citations
https://doi.org/10.1038/s41467-022-31799-y
Hsp90ab1 stabilizes LRP5 to promote epithelial–mesenchymal transition via activating of AKT and Wnt/β-catenin signaling pathways in gastric cancer progression
2018 · Oncogene · 124 citations
https://doi.org/10.1038/s41388-018-0532-5
Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization
2023 · Nature · 122 citations
https://doi.org/10.1038/s41586-023-06809-8
Tumor Exosomes Reprogrammed by Low pH Are Efficient Targeting Vehicles for Smart Drug Delivery and Personalized Therapy against their Homologous Tumor
2021 · Advanced Science · 107 citations
https://doi.org/10.1002/advs.202002787
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat